Abcore approached Pivotal Scientific to exclusively manage the sale of their company to Fortis Life Sciences, relying on our proven expertise in M&A consultancy. Having been approached by Fortis with a potential deal, Abcore, who is inexperienced in managing such transactions, sought our guidance to navigate the process effectively. Pivotal Scientific led the negotiation, securing a favourable price and managing the entire sale process from start to finish. We successfully negotiated the terms to obtain a Letter of Intent (LOI) and ensured a smooth transition through to the completion of the sale.
Pivotal Scientific performed commercial due diligence on Fortis Life Sciences ahead of the sale of Abcore. Given the close involvement with Abcore, both for Pivotal Scientific, and for Tim personally, we were thrilled that Fortis Life Sciences was a strong partner for the next stage of Abcore’s journey.
We are delighted to have received a testimonial from David and Jennifer, the senior management team at Abcore:
“The unwavering support and guidance we received from Pivotal Scientific throughout Abcore’s development meant they could understand our company going into its sale. We are pleased with the quality and commitment of the M&A team throughout the process and are thrilled with the outcome.“
Learn more about Pivotal Scientific’s involvement with this deal in our blog post
